What happened: Allstate alleges a New Jersey pharmacy operating from a hospital lobby submitted more than $524,000 in fraudulent No-Fault auto insurance claims for unnecessary prescription drugs.
Who's involved: Four Allstate entities as plaintiffs; eMED Pharmacy Corp. and its two co-owners as defendants.
What's at stake: More than $524,869 in actual damages, with triple damages sought under federal racketeering laws.
Why it matters: The case maps out an alleged pharmacy billing pipeline from prescription steering through forged delivery receipts - a playbook claims and SIU teams will want to study.
Where it stands: Complaint filed November 3, 2026. No court ruling yet.
The medical records showed one drug order for the patient: over-the-counter Tylenol. But according to Allstate, the pharmacy had already billed for five prescription drugs under the same doctor's name.
That detail sits at the center of a new federal lawsuit filed in the Eastern District of New York, where four Allstate entities allege eMED Pharmacy Corp. ran a No-Fault auto insurance billing scheme from inside a New Jersey hospital. The complaint, filed November 3, 2026, seeks more than $524,869 in damages - and triple that amount under federal racketeering laws.
The pharmacy's address tells part of the story. eMED Pharmacy operated from the premises of Hudson Regional Hospital in Secaucus, New Jersey, under what the complaint calls a "Timeshare License Agreement." That agreement, according to the filing, only permitted the pharmacy to conduct "administrative functions" - not to run a full operation. The complaint alleges eMED Pharmacy's use of the hospital space was limited to morning and afternoon blocks on Monday through Thursday and a morning block on Friday, yet the pharmacy operated well beyond those hours.
The hospital is owned by a non-party whom the complaint describes as having "a long and well-documented history of involvement in No-Fault fraud schemes." Allstate alleges this individual also controlled a network of surgery centers and medical clinics whose providers steered prescriptions to eMED Pharmacy.
The alleged pipeline worked like this, according to the filing: marketers recruited prescribing providers into the pharmacy's referral network - a process the complaint calls "onboarding." Those providers, working at the hospital, affiliated surgery centers, and a chain of medical clinics, would phone in prescriptions for No-Fault auto accident claimants. The prescriptions were called in by telephone rather than sent through the electronic systems New York requires, because eMED Pharmacy sat across the state line in New Jersey and fell outside the electronic prescribing rules.
One of the pharmacy's co-owners acknowledged this advantage under oath, the complaint states, telling questioners he could "actually quote you the law word for word" on the exemption. Telephone prescriptions were preferred, according to the filing, because eMED Pharmacy could bill for drugs without needing the prescriber's signature.
The complaint details several claims where prescriptions allegedly arrived at eMED Pharmacy before the patient ever saw the prescribing provider. In one case, the filing alleges a prescription for a combination pain drug was transmitted on March 19, 2024 - a day before the claimant's shoulder surgery on March 20, 2024. None of the surgical reports from that procedure mention the prescribed drug, the complaint states.
In another case, the complaint says prescriptions were phoned in for a claimant on July 26, 2024. According to the filing, the provider's own examination report - from an appointment ten days earlier - did not include any prescription drug orders. The claimant did not undergo surgery with that provider until July 29, 2024.
Then there is the billing gap the complaint highlights in a third claimant's file. According to the filing, a provider ordered just one medication for a surgical patient in his post-operative care plan: over-the-counter Tylenol. Yet eMED Pharmacy billed Allstate for five prescription drugs - esomeprazole magnesium, naproxen, ondansetron, Percocet, and docusate sodium - supported by telephone prescriptions under the same provider's name. Those prescriptions were transmitted nine days before the post-operative exam, according to the filing. When one of the co-owners was asked under oath whether it was possible the provider had not actually prescribed those medications, the complaint says he gave no response.
The complaint alleges the scheme pushed expensive prescription drugs when cheaper alternatives were available without a prescription. The filing singles out generic Vimovo - a combination pain and stomach-protection pill - which eMED Pharmacy allegedly billed at $2,149.60 for a 30-day supply. Both of its component drugs are available over the counter, the complaint states, for less than $50 combined. The wholesale cost to eMED Pharmacy was approximately $600, according to the filing.
The complaint also alleges eMED Pharmacy billed over $2,154 for a 30-day supply of a topical anti-inflammatory spray that could be bought at wholesale for around $350. The filing states these medications were prescribed according to "predetermined protocols" regardless of medical need, and that many were not approved to treat the musculoskeletal injuries the claimants had reported.
Marketers who steered prescriptions to the pharmacy were paid bonuses based on volume, the complaint alleges.
The filing goes further. The complaint alleges delivery receipts for several claimants contained "forged or unauthorized signatures," and includes side-by-side comparisons of claimants' actual signatures against those appearing on eMED Pharmacy's delivery documents.
Allstate brings five claims: two federal racketeering counts, fraud, a claim for keeping money it should not have kept, and a request for a court order declaring eMED Pharmacy has no right to collect No-Fault payments. The racketeering counts carry the possibility of triple damages.
The complaint alleges the scheme violated New Jersey's Codey Law, which bans practitioners from steering patients to healthcare services - including pharmacies - in which they or their close family members hold a financial interest. Allstate says providers at the hospital, its affiliated surgery centers, and a related chain of medical clinics all had prohibited financial ties to eMED Pharmacy through the hospital's ownership structure.
The filing references four prior federal suits involving one of the co-owners in connection with other alleged No-Fault fraud schemes.
Claims and SIU teams handling No-Fault pharmacy billing may want to note the specific mechanics alleged here: telephone prescriptions used to bypass electronic safeguards, prescriptions transmitted before patients were examined, and delivery receipts with mismatched signatures.
The allegations in the complaint have not been tested, and no court has made any ruling on the merits.
